3D Genome Architecture Shifts Differently in Normal Aging vs. Neurodegeneration

The three-dimensional architecture of our genome—how DNA folds and organizes inside the nucleus—changes with age, but not all changes are equal. This Genome Research study mapped 3D genome landscapes across aging mice and models of neurodegenerative diseases, revealing surprisingly divergent patterns. Normal aging showed specific changes in how chromosomes interact and which genes become accessible, while Alzheimer's and Huntington's disease models exhibited distinct architectural disruptions. These differences matter because 3D genome organization controls which genes are turned on or off. The finding that disease-associated changes differ from normal aging suggests neurodegenerative conditions aren't simply "accelerated aging" but involve unique molecular reprogramming. While this is mouse work requiring human validation, it opens new therapeutic possibilities: interventions might target the specific 3D genome alterations seen in disease while preserving beneficial age-related adaptations. Understanding these architectural differences could help explain why some aging brains remain sharp while others succumb to dementia, even at similar chronological ages.